Skip to main content

Security report for vorwartspharma.lv

SIA Vorwarts Pharma · Healthcare · Latvia

Medium risk. 8 critical or high findings in GDPR outside view, Security headers and 2 other checks.

Security score

55/100

Risk levelMedium

0–100, higher is better. How it is calculated

SIA Vorwarts Pharma is a Latvian pharmaceutical company specializing in the development, manufacturing, and wholesale distribution of medicines and dietary supplements. The company maintains long-term contracts with leading European pharmaceutical manufacturers and offers a product line of approximately 40 items aimed at enhancing human well-being. The website demonstrates a professional digital presence built on WordPress with WooCommerce and Elementor, supporting multilingual content for Latvian, Russian, Estonian, and Lithuanian audiences. Security posture is adequate with HTTPS enabled and secure forms, though additional security headers and incident response policies are recommended. Privacy and terms of service pages are present, but cookie consent mechanisms are lacking, which may impact GDPR compliance. Overall, the company presents itself as a credible small-sized healthcare business with a solid market position in Latvia and neighboring countries.

Scanned

NIS2 and GDPR posture

GDPR outside view
10/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

8 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching vorwartspharma.lv

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
70
Email security
75
DNS health
80
Network security
20
GDPR outside view
10
Average
55

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company operates primarily in the healthcare sector, focusing on pharmaceutical wholesale and manufacturing. Its business model revolves around product development and distribution, targeting pharmacies and health-conscious consumers in Latvia and other European markets such as Ukraine, Poland, and Italy. The presence of GMP certification and a special license for pharmaceutical wholesale enhances its credibility. Partnerships with multiple European pharmaceutical firms indicate a robust supply chain and market integration. The website's multilingual support and e-commerce capabilities suggest an intent to expand reach and facilitate online sales. The company appears to be small-sized with a focused product portfolio and regional market presence.

Security posture

The website employs HTTPS and secure contact forms, which are positive security indicators. However, the absence of key security headers like Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options reduces the overall security posture. No visible vulnerabilities or exposed sensitive data were detected in the HTML content. The lack of an incident response policy or dedicated security contact channels is a gap in security governance. Privacy compliance is partially addressed with a privacy policy and terms of service, but the missing cookie consent mechanism is a compliance risk under GDPR. Regular updates and enhanced security headers are recommended to improve resilience against common web threats.

Recommendations

  1. Implement comprehensive security headers including CSP, X-Frame-Options, and X-Content-Type-Options to mitigate common web vulnerabilities.
  2. Add a cookie consent banner or mechanism to ensure GDPR compliance and improve user privacy transparency.
  3. Publish a security policy and incident response contact information to enhance trust and preparedness.
  4. Regularly audit and update WordPress plugins and themes to prevent exploitation of known vulnerabilities.
  5. Consider engaging a professional security assessment to identify and remediate potential hidden risks.

Contact details published on the site

Addresses
Legal name
SIA Vorwarts Pharma
VAT number
LV50203197781
Registration number
50203197781
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
SIA Vorwarts Pharma
Description
Farmācijas uzņēmums, kas nodarbojas ar zāļu un uztura bagātinātāju vairumtirdzniecību. Galvenie darbības virzieni ir zāļu un uztura bagātinātāju izstrāde un ražošana. Uzņēmumam ir daudzu gadu pieredze un ilgtermiņa līgumi ar vadošajām Eiropas farmācijas rūpnīcām. Zīmola līnijā ir aptuveni 40 produkti, kas veicina cilvēku labsajūtu ar augstu kvalitāti un biopieejamību. Latvijas tirgum tiek reģistrēti uztura bagātinātāji, kas ir ieguvuši uzticību Ukrainas, Polijas un Itālijas tirgos.
Key services
Zāļu izstrāde, Uztura bagātinātāju izstrāde, Ražošana, Vairumtirdzniecība
Content quality
good
Branding
consistent

Technology

Stack
WordPress, WooCommerce, Elementor, Yoast SEO, Google Tag Manager, MakeCommerce payment gateway, TranslatePress multilingual
Frameworks
WooCommerce, Elementor
Platforms
WordPress
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
75/100
Good practices seen
  • HTTPS enabled
  • No exposed sensitive data in HTML
  • Secure contact form with required fields

Analytics and tracking

Services
Google Tag Manager
Tracking level
moderate
Privacy practices
basic

Advertising

Marketing tools
Yoast SEO
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content.
  2. WHOIS data unavailable due to query limit error.
  3. Website uses modern WordPress ecosystem with WooCommerce and Elementor.
  4. Contact information is clearly provided with multiple channels.
  5. Privacy and terms pages exist but cookie consent mechanism is missing.
  6. Security headers are minimal; HTTPS is enabled.
  7. No visible security or incident response policy.
  8. Business operates in pharmaceutical wholesale and manufacturing sector.
  9. Multiple European partners and certifications are displayed.
  10. No suspicious or malicious content detected.
Technical notes

Notes

The website is built on a modern WordPress platform using WooCommerce for e-commerce functionality and Elementor for page building. It integrates third-party services such as Google Tag Manager for analytics and MakeCommerce for payment processing. The site is multilingual, supporting Latvian, Russian, Estonian, and Lithuanian languages via TranslatePress. Performance is moderate with optimized images and responsive design, though some accessibility features could be improved. SEO is supported by Yoast SEO plugin with proper meta tags and structured data in JSON-LD format. Hosting provider details are not explicitly identified. Overall, the technical infrastructure is solid but could benefit from enhanced security configurations and performance tuning.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with vorwartspharma.lv. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review vorwartspharma.lv.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.